B
PRAH

Bellecapital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bellecapital’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-53,662
Closed -$6.73M – 203
2020
Q4 		$6.73M Buy
53,662
+4,989
+10% +$558K 2.24% 13
2020
Q3 		$4.94M Buy
48,673
+2,389
+5% +$244K 2.26% 15
2020
Q2 		$4.5M Buy
46,284
+5,565
+14% +$518K 2.11% 15
2020
Q1 		$3.38M Sell
40,719
-9,159
-18% -$893K 2.16% 13
2019
Q4 		$5.54M Buy
49,878
+3,235
+7% +$333K 2.84% 8
2019
Q3 		$4.63M Sell
46,643
-910
-2% -$90.4K 2.78% 11
2019
Q2 		$4.71M Sell
47,553
-553
-1% -$52.8K 2.93% 11
2019
Q1 		$5.31M Sell
48,106
-13,768
-22% -$1.44M 3.38% 9
2018
Q4 		$5.69M Buy
61,874
+195
+0.3% +$19.7K 4.06% 5
2018
Q3 		$6.8M Sell
61,679
-4,051
-6% -$422K 4.46% 4
2018
Q2 		$6.14M Buy
65,730
+16,270
+33% +$1.4M 4.43% 4
2018
Q1 		$4.1M Sell
49,460
-16,598
-25% -$1.47M 3.84% 8
2017
Q4 		$6.02M Buy
66,058
+20,088
+44% +$1.67M 4.86% 4
2017
Q3 		$3.5M Sell
45,970
-27,210
-37% -$2.06M 4.13% 7
2017
Q2 		$5.49M Buy
+73,180
New +$5.07M 4.81% 6

Other funds holding PRAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Bellecapital's PRAH Position: Q1 2021 in Review

Bellecapital sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 53,662 shares — an estimated $6.73M sold.

Bellecapital first reported a position in PRAH in Q2 2017 and held it in 15 quarters. The position peaked at $6.8M in Q3 2018. 323 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Bellecapital reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Bellecapital sold 53,662 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $6.73M.
  • Bellecapital first reported a position in PRA Health Sciences, Inc. in Q2 2017 and held it in 15 quarters.
  • Bellecapital's PRA Health Sciences, Inc. position peaked at $6.8M in Q3 2018.
  • 323 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Bellecapital's 13F filing for Q1 2021, filed 13 Apr 2021.